Related references
Note: Only part of the references are listed.Characterization of Hepatic and Intestinal Glucuronidation of Magnolol: Application of the Relative Activity Factor Approach to Decipher the Contributions of Multiple UDP-Glucuronosyltransferase Isoforms
Liangliang Zhu et al.
DRUG METABOLISM AND DISPOSITION (2012)
Time-dependent inhibition (TDI) of CYP3A4 and CYP2C9 by noscapine potentially explains clinical noscapine-warfarin interaction
Zhong-Ze Fang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Identification and Characterization of Human UDP-Glucuronosyltransferases Responsible for the In Vitro Glucuronidation of Daphnetin
Si-Cheng Liang et al.
DRUG METABOLISM AND DISPOSITION (2010)
The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential
John O. Miners et al.
DRUG METABOLISM REVIEWS (2010)
Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system
Michael H. Court
DRUG METABOLISM REVIEWS (2010)
Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria
Kavitha Palaniappan et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2010)
Activity of natural compounds on Fusarium verticillioides and fumonisin production in stored maize kernels
A. M. Menniti et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2010)
In vitro anti-inflammatory activity of carvacrol: Inhibitory effect on COX-2 catalyzed prostaglandin E-2 biosynthesisb
Premysl Landa et al.
ARCHIVES OF PHARMACAL RESEARCH (2009)
Liposomal incorporation of carvacrol and thymol isolated from the essential oil of Origanum dictamnus L. and in vitro antimicrobial activity
C. C. Liolios et al.
FOOD CHEMISTRY (2009)
Effect of carvacrol on hepatic marker enzymes and antioxidant status in d-galactosamine-induced hepatotoxicity in rats
Balakrishnan Aristatile et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2009)
Biological and Pharmacological Activities of Carvacrol and Carvacrol Bearing Essential Oils
K. Can Baser
CURRENT PHARMACEUTICAL DESIGN (2008)
Expression of UGT1A and UGT2B mRNA in human normal tissues and various cell lines
Akiko Nakamura et al.
DRUG METABOLISM AND DISPOSITION (2008)
Sulfinpyrazone C-glucuronidation is catalyzed selectively by human UDP-glucuronosyltransferase 1A9
Oranun Kerdpin et al.
DRUG METABOLISM AND DISPOSITION (2006)
Influence of diet type on the inclusion of plant origin active substances on morphological and histochemical characteristics of the stomach and jejunum walls in chicken
D Jamroz et al.
JOURNAL OF ANIMAL PHYSIOLOGY AND ANIMAL NUTRITION (2006)
In vitro-in vivo correlation for drugs and other compounds eliminated by glucuronidation in humans: Pitfalls and promises
JO Miners et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily
PI Mackenzie et al.
PHARMACOGENETICS AND GENOMICS (2005)
Evaluation of 5-hydroxytryptophol and other endogenous serotonin (5-hydroxytryptamine) analogs as substrates for UDP-glucuronosyltransferase 1A6
S Krishnaswamy et al.
DRUG METABOLISM AND DISPOSITION (2004)
Constituents of aromatic plants: carvacrol
M De Vincenzi et al.
FITOTERAPIA (2004)
In vitro antioxidant, antimicrobial, and antiviral activities of the essential oil and various extracts from herbal parts and callus cultures of origanum acutidens
M Sökmen et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2004)
Glucuronidation activity of the UGT2B17 enzyme toward xenobiotics
D Turgeon et al.
DRUG METABOLISM AND DISPOSITION (2003)
Pharmacophore and quantitative structure-activity relationship modeling: Complementary approaches for the rationalization and prediction of UDP-glucuronosyltransferase 1A4 substrate selectivity
PA Smith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Validation of serotonin (5-hydroxtryptamine) as an in vitro substrate probe for human UDP-glucuronosyltransferase (UGT) 1A6
S Krishnaswamy et al.
DRUG METABOLISM AND DISPOSITION (2003)
Characterization of catechol glucuronidation in rat liver
L Antonio et al.
DRUG METABOLISM AND DISPOSITION (2002)